Development of a Novel Cysteine Sulfinic Acid Decarboxylase Knockout Mouse: Dietary Taurine Reduces Neonatal Mortality

  • Park E
  • Park S
  • Dobkin C
  • et al.
N/ACitations
Citations of this article
45Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We engineered a CSAD KO mouse to investigate the physiological roles of taurine. The disruption of the CSAD gene was verified by Southern, Northern, and Western blotting. HPLC indicated an 83% decrease of taurine concentration in the plasma of CSAD - / - . Although CSAD - / - generation (G)1 and G2 survived, offspring from G2 CSAD - / - had low brain and liver taurine concentrations and most died within 24 hrs of birth. Taurine concentrations in G3 CSAD - / - born from G2 CSAD - / - treated with taurine in the drinking water were restored and survival rates of G3 CSAD - / - increased from 15% to 92%. The mRNA expression of CDO, ADO, and TauT was not different in CSAD - / - compared to WT and CSAD mRNA was not expressed in CSAD - / - . Expression of Gpx 1 and 3 was increased significantly in CSAD - / - and restored to normal levels with taurine supplementation. Lactoferrin and the prolactin receptor were significantly decreased in CSAD - / - . The prolactin receptor was restored with taurine supplementation. These data indicated that CSAD KO is a good model for studying the effects of taurine deficiency and its treatment with taurine supplementation.

Cite

CITATION STYLE

APA

Park, E., Park, S. Y., Dobkin, C., & Schuller-Levis, G. (2014). Development of a Novel Cysteine Sulfinic Acid Decarboxylase Knockout Mouse: Dietary Taurine Reduces Neonatal Mortality. Journal of Amino Acids, 2014, 1–12. https://doi.org/10.1155/2014/346809

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free